This page shows the latest Brintellix news and features for those working in and with pharma, biotech and healthcare.
120m kroner and antidepressant Brintellix (vortioxetine) adding another 98m kroner, up from 8m kroner a year ago. ... Brintellix has now been launched in 20 countries and while uptake is "still limited outside the Nordic countries and the Netherlands,"
Brintellix first antidepressant with cognition claim in Europe. Trial found it performed better than Lilly’ s rival Cymbalta. ... The Danish company also has a long-acting version of schizophrenia drug Abilify (aripiprazole) and alcohol addiction
Epilepsy treatment Sabril (vigabatrin) also had a good quarter with sales climbing 42% to 186m krone and Lundbeck also booked 59m krone from antidepressant Brintellix(vortioxetine) in the quarter, although it
Lundbeck launches Brintellix in first EU market. The antidepressant set to sell worldwide. ... Danish pharma company Lundbeck is selling its new antidepressant Brintellix in its home market, the first European launch for the product.
Brintellix was next in spending terms with $7m.
Brexipiprazole is one of a trio of new drugs Lundbeck and alliance partner Otsuka are relying on to drive growth in the coming years, alongside recently launched antidepressant Brintellix (vortioxetine) and
More from news
Approximately 6 fully matching, plus 16 partially matching documents found.
In addition, Lundbeck also has Brintellix (vortioxetine) under review by the EMA, while a once-monthly version of schizophrenia drug Abilify (aripiprazole) is also due to launch during 2013.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.